Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1980 Dec;34(4):265–270. doi: 10.1136/jech.34.4.265

Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants.

D C Poskanzer, J L Sever, P I Terasaki, L B Prenney, J L Sheridan, M S Park
PMCID: PMC1052089  PMID: 7241025

Abstract

HLA phenotypes were correlated with serum antibody titres to eight viruses in patients with multiple sclerosis and two matched control groups in the Orkney Islands. In patients, no specific HLA antigen was associated wtih increased or decreased viral titres. However, HLA-B7 was significantly correlated with higher measles titres in healthy controls. Furthermore, controls who had the HLA haplotypes, B7, DW2 ad B-cell 4, demonstrated significantly higher antibody titres to measles and rubella than controls without these determinants (P less than 0.005). To determine the effect of age, sex, and other variables upon viral titres, regression analysis was undertaken. A significant proportion of measles titre variance in patients was explained by sex and clinical factors. Among normal controls, HLA determinants explained a significant amount of measles and rubella titre variance. These data suggest that viral titres in normal individuals are influenced by certain HLA antigens and give indirect evidence that another, as yet undefined, determinant in the histocompatibility complex governs the immune response.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnason B. G., Fuller T. C., Lehrich J. R., Wray S. H. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci. 1974 Aug;22(4):419–428. doi: 10.1016/0022-510x(74)90078-1. [DOI] [PubMed] [Google Scholar]
  2. Bertrams J., von Fisenne E., Hoher P. G., Kuwert E. Lack of association between HL-A antigens and measles antibody in multiple sclerosis. Lancet. 1973 Aug 25;2(7826):441–441. doi: 10.1016/s0140-6736(73)92296-4. [DOI] [PubMed] [Google Scholar]
  3. Brody J. A., Sever J. L., Henson T. E. Virus antibody titers in multiple sclerosis patients, siblings, and controls. JAMA. 1971 May 31;216(9):1441–1446. [PubMed] [Google Scholar]
  4. Compston D. A., Batchelor J. R., McDonald W. I. B-lymphocyte alloantigens associated with multiple sclerosis. Lancet. 1976 Dec 11;2(7998):1261–1265. doi: 10.1016/s0140-6736(76)92027-4. [DOI] [PubMed] [Google Scholar]
  5. Fewster M. E., Ames F. R., Botha M. C. Measles antibodies and histocompatibility types in multiple sclerosis. J Neurol Sci. 1979 Sep;43(1):19–26. doi: 10.1016/0022-510x(79)90070-4. [DOI] [PubMed] [Google Scholar]
  6. Fewster M. E., Myers L. W., Ellison G. W., Walford R. L. Histocompatibility types and measles antibodies in multiple sclerosis. J Neurol Sci. 1977 Nov;34(2):287–296. doi: 10.1016/0022-510x(77)90076-4. [DOI] [PubMed] [Google Scholar]
  7. Fritze D., Herrmann C., Jr, Naeim F., Smith G. S., Walford R. L. Letter: HL-A antigens in myasthenia gravis. Lancet. 1974 Jul 6;2(7871):43–43. doi: 10.1016/s0140-6736(74)91370-1. [DOI] [PubMed] [Google Scholar]
  8. Jersild C., Svejgaard A., Fog T., Ammitzboll T. HL-A antigens and diseases. I. Multiple sclerosis. Tissue Antigens. 1973;3(4):243–250. doi: 10.1111/j.1399-0039.1973.tb01002.x. [DOI] [PubMed] [Google Scholar]
  9. LILLY F., BOYSE E. A., OLD L. J. GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS. Lancet. 1964 Dec 5;2(7371):1207–1209. doi: 10.1016/s0140-6736(64)91043-8. [DOI] [PubMed] [Google Scholar]
  10. Lehrich J. R., Arnason B. G. Histocompatibility types and viral antibodies. Arch Neurol. 1976 Jun;33(6):404–405. doi: 10.1001/archneur.1976.00500060010003. [DOI] [PubMed] [Google Scholar]
  11. McDevitt H. O., Bodmer W. F. HL-A, immune-response genes, and disease. Lancet. 1974 Jun 22;1(7869):1269–1275. doi: 10.1016/s0140-6736(74)90021-x. [DOI] [PubMed] [Google Scholar]
  12. Mozes E., Fuchs S. Linkage between immune response potential to DNA and X chromosome. Nature. 1974 May 10;249(453):167–168. doi: 10.1038/249167a0. [DOI] [PubMed] [Google Scholar]
  13. Oldstone M. B., Dixon F. J., Mitchell G. F., McDevitt H. O. Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection. J Exp Med. 1973 May 1;137(5):1201–1212. doi: 10.1084/jem.137.5.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Opelz G., Terasaki P. I. Influence of sex on histocompatibility matching in renal transplantation. Lancet. 1977 Aug 27;2(8035):419–421. doi: 10.1016/s0140-6736(77)90606-7. [DOI] [PubMed] [Google Scholar]
  15. Opelz G., Terasaki P., Myers L., Ellison G., Ebers G., Zabriskie J., Weiner H., Kempe H., Sibley W. The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States. Tissue Antigens. 1977 Jan;9(1):54–58. doi: 10.1111/j.1399-0039.1977.tb01080.x. [DOI] [PubMed] [Google Scholar]
  16. Paty D. W., Furesz J., Boucher D. W., Rand C. G., Stiller C. R. Measles antibodies as related to HL-A types in multiple sclerosis. Neurology. 1976 Jul;26(7):651–655. doi: 10.1212/wnl.26.7.651. [DOI] [PubMed] [Google Scholar]
  17. Poskanzer D. C., Prenney L. B., Sheridan J. L., Kondy J. Y. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology. J Epidemiol Community Health. 1980 Dec;34(4):229–239. doi: 10.1136/jech.34.4.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Poskanzer D. C., Sever J. L., Sheridan J. L., Prenney L. B. Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections. J Epidemiol Community Health. 1980 Dec;34(4):258–264. doi: 10.1136/jech.34.4.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Poskanzer D. C., Terasaki P. I., Prenney L. B., Sheridan J. L., Park M. S. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants. J Epidemiol Community Health. 1980 Dec;34(4):253–257. doi: 10.1136/jech.34.4.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sever J. L., Kurtzke J. F., Alter M., Schumacher G. A., Gilkeson M. R., Ellenberg J. H., Brody J. A. Virus antibodies and multiple sclerosis. Arch Neurol. 1971 Jun;24(6):489–494. doi: 10.1001/archneur.1971.00480360023002. [DOI] [PubMed] [Google Scholar]
  21. Symington G. R., Mackay I. R., Whittingham S., White J., Buckley J. D. A 'profile' of immune responsiveness in multiple sclerosis. Clin Exp Immunol. 1978 Feb;31(2):141–149. [PMC free article] [PubMed] [Google Scholar]
  22. Visscher B. R., Myers L. W., Ellison G. W., Malmgren R. M., Detels R., Lucia M. V., Madden D. L., Sever J. L., Park M. S., Coulson A. H. HLA types and immunity in multiple sclerosis. Neurology. 1979 Dec;29(12):1561–1565. doi: 10.1212/wnl.29.12.1561. [DOI] [PubMed] [Google Scholar]
  23. Whitaker J. N., Herrmann K. L., Rogentine G. N., Stein S. F., Kollins L. L. Immunogenetic analysis and serum viral antibody titers in multiple sclerosis. Arch Neurol. 1976 Jun;33(6):399–403. doi: 10.1001/archneur.1976.00500060005002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES